Implications of Enabling Ultra-Sensitive MRD Detection in Early-Stage Lung & Breast Cancer
Time: 4:10 pm
day: Day Two PM
Details:
- Patients who previously report MRD negative with less-sensitive technologies are not truly negative and experience recurrence
- NeXT Personal is a tumor-informed ultra-sensitive ctDNA assay that enables detection down to 1PPM
- Could earlier detection be possible to enable earlier patient intervention
